Product Image
Invitrogen™

ViraPower™ Bsd Lentiviral Support Kit

Invitrogen社のViraPower™レンチウイルスサポートキットには、293FT細胞でレンチウイルス粒子を作成するために必要な試薬が含まれています。 このサポートキットには、パッケージングミックス、Lipofectamine™ 2000および安定発現株選択のためのBlasticidinが含まれています。Virapowerサポートキットは、最新のViraPower™ HiPerform™詳細を見る
製品番号(カタログ番号)数量
K497000
または、製品番号K4970-00
20 reactions
製品番号(カタログ番号) K497000
または、製品番号K4970-00
価格(JPY)
303,600
Each
数量:
20 reactions
Invitrogen社のViraPower™レンチウイルスサポートキットには、293FT細胞でレンチウイルス粒子を作成するために必要な試薬が含まれています。 このサポートキットには、パッケージングミックス、Lipofectamine™ 2000および安定発現株選択のためのBlasticidinが含まれています。

Virapowerサポートキットは、最新のViraPower™ HiPerform™ pLenti6.3およびpLenti7.3ベクターを含む、当社のBlasticidinを含むVirapowerベクターと互換性があります。
研究用途にのみご使用ください。診断目的には使用できません。
仕様
供給タイプLentiviral
使用対象(アプリケーション)ウイルス発現
製品タイプLentiviral Support Kit
数量20 reactions
ベクターpLP
製品ラインViraPower
プロモーターRSV, CMV
Unit SizeEach
組成および保存条件
Contents
The ViraPower™ Bsd Lentiviral Support Kit includes the following components:
• 195 μg of ViraPower™ Packaging Mix (Contains 195 μL of a mixture of pLP1, pLP2, and pLP⁄VSVG plasmids, at 1 μg⁄μL in TE Buffer, pH 8.0)
• 0.75 ml of Lipofectamine™ 2000 (Cat # 11668027)
• 50 mg of Blasticidin powder (Cat # R21001)

Storage
• ViraPower™ Packaging Mix: -20°C
• Lipofectamine™ 2000: +4°C (do not freeze)
• Blasticidin: -20°C

よくあるご質問(FAQ)

I used one of your lentiviral vectors but am observing cytotoxic effects after transduction. Can you please help?

Possible causes include:

- large volume of viral supernatant used for transduction
- cells sensitive to Polybrene regaent
- too much antibiotic used for selection
- antibiotic used too soon after tranduction
- gene of interest is toxic to cells

I transduced my lentiviral stock into my mammalian cell line but am getting poor expression of my gene of interest. What could have happened?

Poor expression could result from low transduction efficiency, too low of a MOI, too much antibiotic used for selection, usage of antibiotic too soon after transduction, harveting cells too soon after transduction, having a gene of interest that is toxic to cells, or rerrangement in the LTR regions of the expression construct plasmid DNA.

I transduced my lentiviral stock into my mammalian cell line but am getting no expression of my gene of interest. What could have gone wrong?

Here are some possible causes and solutions:
- Promoter silencing; CMV promoter is prone to silencing especially in mouse and rat cells, screen multiple antibiotic resistant clones and select the one with the highest expression levels
- Viral stocks stored incorrectly; aliquot and store at -80 degrees C, do not freeze/thaw more than 3 times

I prepared a lentiviral stock using one of your lentiviral vectors. I am trying to determine the titer using antibiotic selection but am not able to since the cells are very confluent and I am not getting antibiotic-resistant clones. Can you please offer some tips?

Here are some possible causes and solutions:

- Too little antibotic used for selection
- Selection performed on confluent cells; replate cells
- Viral supernatant not diluted sufficiently; titer lentivus using a wider range of 10-fold serial dilutions

I am using one of your lentiviral vectors and am getting a low lentiviral titer. Can you offer some troubleshooting tips?

Possible causes include:

- low transfection efficiency; Use a high-quality plasmid prep, 293FT cells under passage 16, ensure removal of Geneticin during transfection, ensure correct DNA:lipid ratio, and that cells are plated at the correct confluency
- transfected cells are not cultured in medium containing sodium pyruvate; this reagent provides an extra energy source for cells
- viral supernatant harvested too early; viral supernatants can generally be collected 48-72 hrs post-transfection
- viral supernatant too dilute; concentrate virus using CsCl purification
- viral supernatant frozen and thawed multiple times; 3 times should be the maximum freeze/thaw
- gene of interest is large; viral titers decrease as size of insert increases, inserts larger than 5.6 kb are not recommended
- rearrangement in the LTR region of the epxression construct plasmid DNA; use Stb3 cells for transformatin of the lentiviral construct
- poor choice of titering cell line; use HT1080 cells or similar cell line
- Polybrene reagent is not included during transduction; transduce lentiviral construct into cells in the presence of Polybrene reagent
- Lipofectamine reagent handled incorrectly; ensure proper storage and mix gently before use
- Use fluorescence micrscopy to check titer with HiPerform FastTiter lentivirus

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

引用および参考文献 (1)

引用および参考文献
Abstract
P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
Authors:Wang KC, Kim JA, Sivasankaran R, Segal R, He Z,
Journal:Nature
PubMed ID:12422217
In inhibiting neurite outgrowth, several myelin components, including the extracellular domain of Nogo-A (Nogo-66), oligodendrocyte myelin glycoprotein (OMgp) and myelin-associated glycoprotein (MAG), exert their effects through the same Nogo receptor (NgR). The glycosyl phosphatidylinositol (GPI)-anchored nature of NgR indicates the requirement for additional transmembrane protein(s) to transduce the inhibitory signals ... More